Genetic Analysis Identifying Late Occurring Complications in Childhood Cancer Survivors (ALTE03N1)
Full IRB Study Title:
ALTE03N1: Key Adverse Events After Childhood Cancer
IRB Study ID: 1008790-1
For complete study information, please view the study on clinicaltrials.gov.
Study Sponsor:
Children’s Oncology Group. Collaborated by the National Cancer Institute.
We are currently recruiting
If you are interested in this study or have questions about your child's eligibility, please contact:
Rebecca D. Considine Research Institute, 330-543-3193 or email research@akronchildrens.org